MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.25 USD | +0.47% |
|
-2.82% | +5.71% |
| 09-12 | Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors | MT |
| 09-11 | Merck: positive results for HPV vaccine | CF |
Main competitors
| Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG Refinitiv | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|
B- | 291B | ||||||||
C+ | 829B | ||||||||
B | 583B | ||||||||
C+ | 397B | ||||||||
C+ | 344B | ||||||||
A+ | 255B | ||||||||
B+ | 248B | ||||||||
B- | 232B | ||||||||
C+ | 177B | ||||||||
C+ | 168B | ||||||||
B+ | 144B | ||||||||
B- | 101B | ||||||||
B | 98.51B | ||||||||
B | 87.89B | ||||||||
A- | 75.39B | ||||||||
A- | 69.9B | ||||||||
B+ | 47.01B | ||||||||
B | 46.8B | ||||||||
B | 40.57B | ||||||||
| Average | B | 222.92B | |||||||
| Weighted average by Cap. | B |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector ratings
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition